Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Processa Pharmaceuticals Inc
(NQ:
PCSA
)
1.530
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Processa Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
Next >
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference
February 21, 2024
Via
Investor Brand Network
Exposures
Product Safety
How Is The Market Feeling About Processa Pharma?
February 09, 2024
Via
Benzinga
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
February 08, 2024
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public Offering
February 02, 2024
Via
Investor Brand Network
Exposures
Product Safety
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
February 02, 2024
The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
February 01, 2024
The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
January 29, 2024
Via
AB Newswire
Topics
Retirement
Exposures
Pension
12 Health Care Stocks Moving In Monday's Intraday Session
January 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 29, 2024
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results
January 26, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Pricing Information for $7M Public Offering
January 26, 2024
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
January 26, 2024
Via
Benzinga
Crude Oil Down 1%; American Express Shares Rise After Q4 Results
January 26, 2024
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Friday. The Dow traded up 0.32% to 38,170.95 while the NASDAQ rose 0.10% to 15,525.24. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Via
Benzinga
What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?
January 26, 2024
Processa Pharmaceuticals stock surge - 148.8% gain to $5.10 post Next Generation Capecitabine (NGC-Cap) Phase 1b success.
Via
Benzinga
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
January 26, 2024
From
Processa Pharmaceuticals, Inc.
Via
GlobeNewswire
Intel, Nvidia, AMD, Processa Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings
January 25, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?
January 25, 2024
Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.
Via
InvestorPlace
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
January 25, 2024
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 25, 2024
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Completes Phase 1b Safety Evaluation of NGC-Cap
January 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Why Processa Pharmaceuticals Stock Is Soaring
January 25, 2024
Processa Pharmaceuticals shares are soaring Thursday after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Processa...
Via
Benzinga
Exposures
Product Safety
Dow Surges Over 100 Points; US GDP Growth Tops Estimates
January 25, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.33% to 37,932.33 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the...
Via
Benzinga
US Stocks Higher; Nasdaq Jumps 100 Points
January 22, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Gains 1%; State Street Reports Upbeat Earnings
January 19, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.